Trial Profile
Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus XR) Based Immunosuppression Regimen in Kidney Transplant Recipients
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 16 Apr 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 23 Mar 2021 Status changed from recruiting to completed.
- 02 May 2019 Planned End Date changed from 1 Mar 2019 to 1 Mar 2020.
- 02 May 2019 Planned primary completion date changed from 1 Mar 2019 to 1 Mar 2020.